Laird Norton Wetherby Trust Company’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.3M Sell
102,602
-448
-0.4% -$52.4K 0.25% 64
2026
Q1
$12.5M Sell
103,050
-26,308
-20% -$3.04M 0.27% 60
2025
Q4
$13.7M Buy
+129,358
New +$12.1M 0.29% 56
2021
Q2
– Sell
-6,744
Closed -$524K – 168
2021
Q1
$524K Sell
6,744
-17
-0.3% -$1.25K 0.06% 88
2020
Q4
$528K Buy
+6,761
New +$517K 0.06% 84

Other funds holding MRK

Laird Norton Wetherby Trust Company's MRK Position: Q2 2026 in Review

Laird Norton Wetherby Trust Company reduced its Merck (MRK) stake by 0.43% in Q2 2026, selling an estimated $52.4K and leaving 102,602 shares worth $13.3M. The position accounts for 0.25% of the portfolio, ranked #64.

Laird Norton Wetherby Trust Company first reported a position in MRK in Q4 2020 and has held it in 5 quarters since. The position peaked at $13.7M in Q4 2025. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Laird Norton Wetherby Trust Company held 102,602 shares of Merck worth $13.3M as of Q2 2026.
  • Laird Norton Wetherby Trust Company sold 448 Merck shares in Q2 2026, an estimated $52.4K.
  • Merck made up 0.25% of Laird Norton Wetherby Trust Company's portfolio in Q2 2026, its #64 holding.
  • Laird Norton Wetherby Trust Company first reported a position in Merck in Q4 2020 and has held it in 5 quarters since.
  • Laird Norton Wetherby Trust Company's Merck position peaked at $13.7M in Q4 2025.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Laird Norton Wetherby Trust Company's 13F filing for Q2 2026, filed 14 Aug 2026.